GSK partners with Government on quadrivalent flu jab

GSK Australia is partnering with the Australian Government to provide a quadrivalent influenza vaccine for the National Immunisation Program for the 2016 season. Fluarix® Tetra is a four-strain flu vaccine indicated for the active immunisation of adults and children from three years of age for the prevention of influenza disease caused by the influenza virus